Aggregator

Imunomodulacijske intervencije (terapije koje ciljaju na imunosni sustav) za žarišnu epilepsiju

2 years 1 month ago
Imunomodulacijske intervencije (terapije koje ciljaju na imunosni sustav) za žarišnu epilepsiju Ključne poruke Imunomodulacijske intervencije su terapije koje ciljaju na imunosni sustav. Fokalnu epilepsiju karakteriziraju napadaji koji proizlaze iz određenog područja mozga. Imunomodulacijske intervencije bile su znatno učinkovitije od placeba u smanjenju učestalosti napadaja u djece i odraslih s fokalnom epilepsijom. Što je epilepsija? Epilepsija je često neurološko stanje koje pogađa oko 50 milijuna ljudi diljem svijeta. Fokalnu epilepsiju karakteriziraju napadaji koji proizlaze iz...

Cjepivo palivizumaba za sprječavanje infekcije respiratornim sincicijskim virusom u djece oboljele od cistične fibroze

2 years 2 months ago
Cjepivo palivizumaba za sprječavanje infekcije respiratornim sincicijskim virusom u djece oboljele od cistične fibroze Istraživačko pitanje U ovom Cochrane sustavnom pregledu literature analizirani su dokazi o učincima cijepljenja djece oboljele od cistične fibroze s palivizumabom u svrhu sprječavanja infekcije respiratornim sincicijskim virusom. Dosadašnje spoznaje Respiratorni sincicijski virus najčešće uzrokuje plućne infekcije u novorođenčadi i djece. Premda slučajevi nisu ozbiljni u većine djece, djeca s cističnom fibrozom mogu biti izložena većem riziku za teške infekcije pluća od...

Jesu li dodaci s više ili manje soli (natrija) bolji za prerano rođene bebe za sprječavanje bolesti i poboljšanje rasta i razvoja?

2 years 2 months ago
Jesu li dodaci s više ili manje soli (natrija) bolji za prerano rođene bebe za sprječavanje bolesti i poboljšanje rasta i razvoja? Ključne poruke • Tijekom prvih dana nakon rođenja, prerano rođene bebe trebaju niži unos soli (natrija) kako bi se spriječile visoke razine natrija u krvi. Međutim, nismo sigurni postoje li ikakvi učinci na smrt dojenčadi ili na zdravlje novorođenčadi dok su u bolnici. Rast i dugoročni razvoj uvelike su neprijavljeni u istraživanjima o ranom unosu natrija. • Nakon prvih par dana poslije porođaja, prerano rođene bebe trebaju veći unos natrija da bi se spriječile...

Utjecaj praćenja i poticanja rasta kod djece mlađe od pet godina u zemljama niskog i srednjeg dohotka

2 years 2 months ago
Utjecaj praćenja i poticanja rasta kod djece mlađe od pet godina u zemljama niskog i srednjeg dohotka Što je praćenje i poticanje rasta? Puno djece mlađe od pet godina koja žive u zemljama niskog i srednjeg dohotka ne dobivaju odgovarajuću prehranu. To može dovesti do porasta oboljenja, oslabljenog mentalnog razvoja, (što umanjuje školski i radni učinak kasnije u životu) i do smrti. Praćenje i promicanje rasta (engl. Growth monitoring and promotion, GMP) je složena intervencija koje uključuje mjerenje rasta djeteta u redovitim intervalima i ucrtavanje mjerenja u grafikon, u kombinaciji s...

WHO Bulletin's call for papers: Cochrane community encouraged to share their perspectives on strengthening WHO's guidance role

2 years 2 months ago

WHO is planning a landmark issue of its journal, which will focus on its normative leadership function (development of evidence-based guidelines etc). The Cochrane community is encouraged to submit a paper by 1 March 2024. 

One of the key roles of the World Health Organization  (WHO)  is to develop evidence-based guidelines and other forms of guidance to support Member States with public health decision-making. Cochrane supports this normative function through our ongoing collaboration, including through providing evidence synthesis and methodological support for WHO’s consideration in the development of new guidance.

WHO is planning a landmark issue of its journal, the Bulletin of World Health Organization (the Bulletin), which will focus on its normative leadership function. This issue will publish in October 2024 to coincide with the annual World Evidence-Based Health Care Day. WHO has launched a request for papers and is particularly interested in country level perspectives and in articles that propose innovative but feasible ways by which the WHO can further strengthen its normative leadership and guidance role.

Topics of interest include:

  • Where has WHO succeeded in its normative leadership role? 
  • In what specific areas has it successfully shaped global health, and why were these initiatives successful? 
  • Where has WHO normative guidance been less impactful? If so, why was this the case, and what lessons can be learnt to improve impact in the future?
  • What does the future of WHO’s normative function look like, particularly in the context of digital technology and artificial intelligence? 
  • What aspects of the Organization’s mandate, structure, function and administration need to be further strengthened or changed?

Due to Cochrane’s breadth of expertise and knowledge in this area, Cochrane’s Groups and Networks across the world are encouraged to consider submitting a paper to this issue.

The deadline for submissions is 1 March 2024. 

 

Tuesday, December 5, 2023
Muriah Umoquit

Cochrane seeks Deputy for Operations Management

2 years 2 months ago

Title: Deputy for Operations Management
Specifications: Permanent – Full Time
Salary:  £70,000 per Annum
Location: Remote - Ideally based in the UK, Germany or Denmark. Candidates from the rest of the world will be considered; however, Cochrane’s Central Executive Team is only able to offer consultancy contracts outside these countries.
Closing date: 06 November 2023

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into four directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

Are you a dynamic leader with a passion for excellence in editorial operations? We are looking to hire for a newly created role of Deputy for Operations Management. This role will lead a senior team and deputise for the Editor in Chief, therefore being at the forefront of Cochrane’s mission to optimise workflow, enhance processes, and ensure the successful delivery of projects and strategies to ultimately make a significant impact on healthcare knowledge worldwide.

You will collaborate closely with the Editor in Chief, and with the Evidence Production & Methods Directorate senior team and project leaders, bridging the gap between them and the Publishing & Technology Directorates.

Key Responsibilities:

  • Contribute to Cochrane’s organisational strategies, lead budget and planning processes, and step in for the Editor in Chief when required
  • Align operations priorities and objectives across the directorate, optimise day-to-day operations, and oversee complaint management and resolution
  • Drive innovation and improvements in internal processes
  • Monitor and report performance metrics, coordinate financial planning, and negotiate contracts with vendors

Lead and facilitate communication among senior team members, identify directorate-level issues, monitor workload and capacity, and support skills development
 
The ideal candidate will possess strong leadership skills and the ability to manage relationships with key stakeholders both internal and external to the business. They will ideally come from a scholarly publishing background - preferably within the STM field, and have significant experience in a senior editorial operations role. We will also be looking for demonstrable experience using metrics to enhance business performance and financial acumen, as well as the ability to lead a team through digital transformation.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everything we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

  • An opportunity to truly impact health globally
  • A flexible work environment
  • A comprehensive onboarding experiences
  • An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

  • If you’re interested in finding out more about this amazing new role, get in touch with Rhianna Patmore at Inspired Selection by sending your CV to r.patmore@inspiredselection.com.
  • The deadline to receive your application is 06 November 2023
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
  • Read our Recruitment Privacy Statement
Wednesday, November 1, 2023 Category: Jobs
Lydia Parsonson

Koja je najbolja ciljana razina šećera u krvi žena koje razviju trudnički (gestacijski) dijabetes?

2 years 2 months ago
Koja je najbolja ciljana razina šećera u krvi žena koje razviju trudnički (gestacijski) dijabetes? Istraživačko pitanje I do četvrtine trudnica razvije trudnički dijabetes, odnosno gestacijski dijabetes melitus (GDM), ovisno o njihovoj etničkoj pripadnosti i dijagnostičkim kriterijima koji se koriste. GDM se manifestira kao povišena razina šećera glukoze u krvi (hiperglikemija) tijekom trudnoće te je povezana s povećanim rizikom od razvoja visokog krvnog tlaka (hipertenzija) i proteina u urinu tijekom trudnoće (preeklampsija). Za žene s dijagnozom GDM-a veća je vjerojatnost da će imati porod...

Cochrane seeks Cochrane Support Manager

2 years 2 months ago

Specifications: Permanent – Full Time
Salary:  £41,191 per Annum  
Location: Remote - Ideally based in the UK, Germany or Denmark. Candidates from the rest of the world will be considered; however, Cochrane’s Central Executive Team is only able to offer consultancy contracts outside these countries.
Closing date: 22 Oct 2023

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into four directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

The Cochrane Support team is the first point of contact for the international Cochrane community. We provide technical and user support to Cochrane editorial teams, review authors, and subscribers to Cochrane RevMan and Cochrane Interactive Learning; and handle enquiries from members of the public about Cochrane’s work.    

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everything we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust.  

You can expect: 

  • An opportunity to truly impact health globally  
  • A flexible work environment  
  • A comprehensive onboarding experiences
  • An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

  • For further information on the role and how to apply, please click here
  • The deadline to receive your application is 22nd Oct, 2023.
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples. 
  • Read our Recruitment Privacy Statement
Monday, October 9, 2023 Category: Jobs
Lydia Parsonson

Koji lijekovi smanjuju iritabilnost, agresiju i samoozljeđivanje u osoba s poremećajem iz autističnog spektra (ASD)?

2 years 2 months ago
Koji lijekovi smanjuju iritabilnost, agresiju i samoozljeđivanje u osoba s poremećajem iz autističnog spektra (ASD)? Ključne poruke • Samo tri vrste lijekova pokazale su smanjenje simptoma iritabilnosti, agresije i samoozljeđivanja u usporedbi s placebom (lažni lijek). Atipični antipsihotici druge generacije vjerojatno smanjuju iritabilnost i agresiju, no čini se da imaju malen ili nikakav učinak na samoozljeđivanje. Lijekovi za poremećaj pažnje i hiperaktivnost (ADHD, engl. Attention-deficit/hyperactivity disorder) mogu smanjiti iritabilnost, ali dokazi o tome nisu sigurni. Neurohormoni...

Imunoterapija naspram kemoterapije za liječenje inoperabilnog ili metastatskog raka mokraćnog mjehura

2 years 2 months ago
Imunoterapija naspram kemoterapije za liječenje inoperabilnog ili metastatskog raka mokraćnog mjehura Istraživačko pitanje Kako djeluje imunoterapija (novije liječenje koje djeluje preko imunosnog sustava tijela) u usporedbi s kemoterapijom (liječenje koje ubija stanice raka) kod osoba s rakom mokraćnog mjehura koji se proširio po cijelom tijelu ili s rakom gornjeg mokraćnog sustava koji se proširio po cijelom tijelu ili kod kojih kirurško liječenje nije moguće zbog uznapredovalog stadija raka. Dosadašnje spoznaje Do prije nekoliko godina, liječenje raka mokraćnog mjehura koji se proširio na...

Kako možemo bolje komunicirati s ljudima i zajednicama o mjerama koje pomažu u prevenciji i kontroli COVID-19?

2 years 2 months ago
Kako možemo bolje komunicirati s ljudima i zajednicama o mjerama koje pomažu u prevenciji i kontroli COVID-19? Ključne poruke - Tijekom pandemije, vlade i druga tijela moraju jasno komunicirati s javnošću o tome kako se ljudi mogu zaštititi. Ta se komunikacija mora temeljiti na povjerenju i dobrom planiranju. Ljudi i zajednice pogođeni pandemijom trebaju biti uključeni u planiranje i komunikaciju. Komunikacija bi trebala doprijeti do svih ljudi u zajednici, uključujući one koji imaju problema s čitanjem i pisanjem, ljude koji govore jezike koji nisu dominantni jezik zajednice i ljude koji se...

Djeca s kroničnom boli koja nije povezana s rakom, iskustva njihovih obitelji i razumijevanje njihovog stanja i liječenje boli: meta-etnografija

2 years 2 months ago
Djeca s kroničnom boli koja nije povezana s rakom, iskustva njihovih obitelji i razumijevanje njihovog stanja i liječenje boli: meta-etnografija Cilj Cochraneovog sustavnog pregleda Cilj ove Cochraneove sinteze kvalitativnih dokaza bio je otkriti kako djeca i mladi koji imaju kroničnu bol i njihove obitelji: 1) razmišljaju o kroničnoj boli; 2) žive s kroničnom boli; 3) razmišljaju o tome kako su zdravstvene i socijalne službe liječile njihovu bol; i 4) što žele od usluga i liječenja. Kako bismo odgovorili na ova pitanja, pretražili smo, analizirali i objedinili nalaze svih relevantnih...

Odgođeno propisivanje recepata za antibiotike za infekcije respiratornog trakta

2 years 2 months ago
Odgođeno propisivanje recepata za antibiotike za infekcije respiratornog trakta Istraživačko pitanje Istražili smo učinak odgode propisivanja recepata za antibiotike u usporedbi s neposrednim propisivanjem recepata za antibiotike te terapiju bez antibiotika kod osoba s infekcijama dišnih puteva, uključujući upalu grla, infekciju srednjeg uha, kašalj (bronhitis) i prehladu. Dosadašnje spoznaje Propisivanje veće količine antibiotika povećava rizik od nuspojava i dovodi do većih troškova zdravstvene zaštite te većih stopa antibakterijske rezistencije. Jedna od strategija za smanjenje...

Je li podrška disanju kroz nos učinkovita kod beba kojima je potrebna pomoć pri disanju pri rođenju?

2 years 2 months ago
Je li podrška disanju kroz nos učinkovita kod beba kojima je potrebna pomoć pri disanju pri rođenju? Ključne poruke 1. Kod novorođenčadi kojima je potrebna pomoć pri disanju odmah nakon rođenja, u rađaonici, neka su istraživanja pokazala da je potpora disanju kroz nos (nazalno sučelje) učinkovitija nego kroz masku za lice (prekriva nos i usta) ili laringealnu masku (LMA; cijev za disanje, umetnuta kroz usta). 2. Pružanje potpore disanju bebama kroz nos u usporedbi s maskom za lice u rađaonici može imati mali ili nikakav učinak na broj beba koje umru prije otpusta. Podrška bebama da dišu na...